LINCOLN

** Shares of Lincoln Pharmaceuticals LINP.NS fall 3.8% to 639.5 rupees, set to log losses for fifth straight session

** Co's Q3 consol profit fell 25.9% to 207.7 mln rupees ($2.4 mln) as expenses rose while revenue remained nearly flat y/y

** More than 437,000 shares traded, 7.8x its 30-day moving avg, most in a session in over two months

** LINP rose 29.3% in 2024

($1 = 86.8900 Indian rupees)

(Reporting by Anuran Sadhu in Bengaluru)

(([email protected]; +91 8697274436;))

Nov 14 (Reuters) - Lincoln Pharmaceuticals Ltd LINP.NS:

• SEPT-QUARTER CONSOL NET PROFIT 263.3 MILLION RUPEES

• SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 1.61 BILLION RUPEES

Source text: ID:nBSE4BWQDx

Further company coverage: LINP.NS

(([email protected];;))

Feb 8 (Reuters) - Lincoln Pharmaceuticals Ltd LINP.NS:

• LINCOLN PHARMACEUTICALS DEC-QUARTER CONSOL NET PROFIT 280.4 MILLION RUPEES VERSUS PROFIT 216.1 MILLION RUPEES

• LINCOLN PHARMACEUTICALS DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 1.46 BILLION RUPEES VERSUS 1.34 BILLION RUPEES

Source text for Eikon: ID:nBSE9j6pPR

Further company coverage: LINP.NS

(([email protected];))

** Shares of Lincoln Pharmaceuticals LINP.NS rise as much as 8.5% to 537 rupees, steepest gain since Aug. 24

** Pharma co's Sept-quarter consol net profit jumps 16.6% Y/Y; rev from ops surges 10.9%

** More than 447,000 shares traded by 12.51 p.m. IST, 8.9x its 30-day avg

** Stock last up 7.2%, extending YTD gains to 49.2% against an 18% YTD growth in benchmark Nifty Pharma Index .NIPHARM

(Reporting by Aleef Jahan in Bengaluru)

(([email protected]))

Aug 10 (Reuters) - Lincoln Pharmaceuticals Ltd LINP.NS:

• JUNE-QUARTER CONSOL NET PROFIT 190.1 MILLION RUPEES VERSUS 150.1 MILLION RUPEES

• JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 1.36 BILLION RUPEES VERSUS 1.23 BILLION RUPEES

Source text for Eikon: ID:nBSE1nXp21

Further company coverage: LINP.NS

(([email protected];))

May 25 (Reuters) - Lincoln Pharmaceuticals Ltd LINP.NS:

• DIVIDEND 1.5 RUPEES PER SHARE

• MARCH-QUARTER CONSOL NET PROFIT 125.6 MILLION RUPEES VERSUS 110.2 MILLION RUPEES

• MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 1.12 BILLION RUPEES VERSUS 1.03 BILLION RUPEES

Source text for Eikon: ID:nBSE8Sy3sY

Further company coverage: LINP.NS

(([email protected];))